综合欧美亚洲日本一区,无码专区人妻系列日韩,亚洲中文精品久久久久久,99re6热在线精品视频播放,99re6热在线精品视频播放

產(chǎn)品中心您的位置:網(wǎng)站首頁 > 產(chǎn)品中心 > 生物試劑 > 其他生化試劑 > 355025-13-7Ki16198 355025-13-7

Ki16198 355025-13-7

更新時間:2025-07-14

訪問量:829

廠商性質:經(jīng)銷商

生產(chǎn)地址:

簡要描述:
Ki16198 355025-13-7
上海一基實業(yè)有限公司是主要從事配套試劑的生產(chǎn)和銷售的企業(yè),產(chǎn)品用途:科研實驗,標準對照品研究中心代理的作為一種衡量標準

Ki16198  355025-13-7

Ki-16198
分子式:C24H25ClN2O5S   分子量:488.98
 
產(chǎn)品描述
Ki16198, Ki16425的甲酯, 是LPA 拮抗劑,抑制LPA1-和 LPA3誘導的肌醇磷酸產(chǎn)生,Ki分別為0.34 μM 和0.93 μM,對LPA2具有較弱的抑制作用,對LPA4, LPA5, LPA6沒有抑制活性。
靶點
LPA1
LPA3
       
IC50
0.34 μM (Ki)
0.93 μM (Ki)
       
體外研究
Ki16198 or Ki16425 substantially inhibits LPA1- and LPA3-mediated responses with a similar potency, with low potency to LPA2 and no activity to LPA4, LPA5 and LPA6. Ki16198 (10 μM) is also effective to inhibit migration and invasion responses to LPA in YAPC-PD cancer cell line with a potency similar to that of Ki16425. Ki16198 (10 μM) inhibits the LPA-induced expression of proMMP-9 protein and mRNA in YAPC-PD cells.Ki16198 (1 μM) inhibits the proliferation of lpa1Δ-1 and lpa1Δ+-1 cells by about 70%.
體內研究
Ki16198 (2 mg/kg) significantly decreases the total metastatic node weight in the peritoneal cavity and ascites formation by 50% in YAPC-PD xenograft mouse model.Ki16198 (60 mg/kg orally) significantly inhibits lactate-induced limb lesions in rats.
溶解性
DMSO 96 mg/mL,水 <1 mg/mL,乙醇 35 mg/mL
穩(wěn)定性
2年 -20°C粉狀,6月-80°C溶于DMSO

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數(shù)字),如:三加四=7